Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 11c vs. 12c a year ago
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Pharmaceuticals reports Q1 GAAP EPS 10c, consensus 9c
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Pharmaceuticals Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
-Firdapse® Q4 Net Revenues of $30 Million, FY 19 Net Revenues of $102 Mil.....»»
Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
- Firdapse® Launch Momentum Continues with Q3 Net Revenues of $30.9 Million -Third Quarter GAAP Net Income of $13.6 Million -Catalyst Provides Net Revenue Guidance – Approximately $100 Mil.....»»
PMV Pharmaceuticals reports Q1 EPS (26c) vs. ($2.38) last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aeva Technologies reports Q1 non-GAAP operating loss $15.6M vs. $6.1M last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
InMed Pharmaceuticals reports Q3 EPS (41c) vs. (39c) last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xenon Pharmaceuticals reports Q1 EPS (42c) vs. (22c) last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Pharmaceuticals reports Q1 EPS 7c, consensus (9c)
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
-Firdapse® Q1 2021 Net Revenues of $30.2 Million -First Quarter 2021 GAAP Net Income of $7.7 Million.....»»
Eagle Pharmaceuticals reports Q1 non-GAAP EPS 24c, consensus 65c
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amneal Pharmaceuticals reports Q1 non-GAAP EPS 20c, consensus 18c
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bausch Health reports Q1 GAAP EPS ($1.71) vs. (43c) last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Polydex Pharmaceuticals reports 2021 EPS 6c vs. 7c last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CDTi Advanced Materials, Inc. Reports Year-End 2020 Financial Results
OXNARD, Calif., April 22, 2021 /PRNewswire/ -- CDTi Advanced Materials, Inc. (OTC:CDTI) ("CDTi" or "the Company"), a leader in advanced catalyst technology, reported its .....»»
Aslan Pharmaceuticals reports Q4 EPS (3c) vs. (18c) last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Pharmaceuticals reports Q4 adjusted EPS 12c, consensus 9c
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Pharmaceuticals reports Q4 EPS 11c, consensus 9c
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results
– FDA accepts resubmitted NDA for VP-102 for the trea.....»»
Cimpress reports Q2 GAAP EPS $1.22 vs. $6.81 last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Logitech reports Q4 non-GAAP operating income $79.0M vs. $64.1M last year
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»